Genome Plasticity of agr -Defective Staphylococcus aureus during Clinical Infection
Therapy for bacteremia caused by is often ineffective, even when treatment conditions are optimal according to experimental protocols. Adapted subclones, such as those bearing mutations that attenuate -mediated virulence activation, are associated with persistent infection and patient mortality. To...
Gespeichert in:
Veröffentlicht in: | Infection and immunity 2018-10, Vol.86 (10) |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Therapy for bacteremia caused by
is often ineffective, even when treatment conditions are optimal according to experimental protocols. Adapted subclones, such as those bearing mutations that attenuate
-mediated virulence activation, are associated with persistent infection and patient mortality. To identify additional alterations in
-defective mutants, we sequenced and assembled the complete genomes of clone pairs from colonizing and infected sites of several patients in whom
demonstrated a within-host loss of
function. We report that events associated with
inactivation result in
-defective blood and nares strain pairs that are enriched in mutations compared to pairs from wild-type controls. The random distribution of mutations between colonizing and infecting strains from the same patient, and between strains from different patients, suggests that much of the genetic complexity of
-defective strains results from prolonged infection or therapy-induced stress. However, in one of the
-defective infecting strains, multiple genetic changes resulted in increased virulence in a murine model of bloodstream infection, bypassing the mutation of
and raising the possibility that some changes were selected. Expression profiling correlated the elevated virulence of this
-defective mutant to restored expression of the
-regulated ESAT6-like type VII secretion system, a known virulence factor. Thus, additional mutations outside the
locus can contribute to diversification and adaptation during infection by
mutants associated with poor patient outcomes. |
---|---|
ISSN: | 0019-9567 1098-5522 |
DOI: | 10.1128/IAI.00331-18 |